Showing results (51-60 of 68) with videos related to

Sort By:
Pageof 7
Brain Research Bulletin|September 23, 2010
Effect of pentylenetetrazole and sound stimulation induced single and repeated convulsive seizures on the MDA, GSH and NO levels, and SOD activities in rat liver and kidney tissuesMeltem Ozlen Dillioglugil, Hale Maral Kir, Cennet Demir, et al.
Mental Health in Family Medicine|December 3, 2013
A feasibility study of a telephone-supported self-care intervention for depression among adults with a comorbid chronic physical illness in primary careJane McCusker, Martin Cole, Mark Yaffe, et al.
Journal of Hematology & Oncology|June 8, 2020
A randomized, open-label, Phase III study of obinutuzumab or rituximab plus CHOP in patients with previously untreated diffuse large B-Cell lymphoma: final analysis of GOYALaurie H Sehn, Maurizio Martelli, Marek Trněný, et al.
Reproductive Sciences (Thousand Oaks, Calif.)|June 23, 2025
Beneficial Effects of Alchemilla vulgaris in DHEA-Induced Rat Model of Polycystic Ovary SyndromeZeynep Ece Utkan Korun, Semil Selcen Gocmez, Selenay Furat, et al.
Asian Pacific Journal of Cancer Prevention : APJCP|March 7, 2015
Chemopreventive effects of hydatid disease on experimental breast cancerAhmet Altun, Serpil Unver Saraydin, Sinan Soylu, et al.
BMC Pregnancy and Childbirth|June 14, 2024
Dysbiosis in pregnant mice induced by transfer of human vaginal microbiota followed by reversal of pathological changes in the uterus and placenta via progesterone treatmentGulin Ozcan, Zeynep Gülçe Tanyolaç Talay, Erxiati Paerhati, et al.
Molecular Biology Reports|October 16, 2012
Antitumoral effects of Allium sivasicum on breast cancer in vitro and in vivoBektas Tepe, Ersin Tuncer, Serpil Unver Saraydın, et al.
Leukemia & Lymphoma|June 25, 2016
FDG-PET is prognostic and predictive for progression-free survival in relapsed follicular lymphoma: exploratory analysis of the GAUSS studyLale Kostakoglu, Andre Goy, Giovanni Martinelli, et al.
Blood Advances|April 17, 2020
Impact of bone marrow biopsy on response assessment in immunochemotherapy-treated lymphoma patients in GALLIUM and GOYASarah C Rutherford, Michael Herold, Wolfgang Hiddemann, et al.
The Lancet. Oncology|October 13, 2018
Prognostic value of end-of-induction PET response after first-line immunochemotherapy for follicular lymphoma (GALLIUM): secondary analysis of a randomised, phase 3 trialJudith Trotman, Sally F Barrington, David Belada, et al.
Pageof 7